Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy

Diabetic retinopathy (DR) is a leading cause of vision loss with retinal vascular leakage and/or neovascularization. Current antiangiogenic therapy against vascular endothelial growth factor (VEGF) has limited efficacy. In this study, we applied a new technology of comparative ligandomics to diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales: LeBlanc, Michelle E., Wang, Weiwen, Chen, Xiuping, Caberoy, Nora B., Guo, Feiye, Shen, Chen, Ji, Yanli, Tian, Hong, Wang, Hui, Chen, Rui, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379984/
https://www.ncbi.nlm.nih.gov/pubmed/28330905
http://dx.doi.org/10.1084/jem.20161802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379984/
https://www.ncbi.nlm.nih.gov/pubmed/28330905
http://dx.doi.org/10.1084/jem.20161802

Ejemplares similares